Atropine eye drops for preventing nearsightedness in children
Treatments studied
Part of Eyes & vision clinical trials.
This study tests whether low-dose atropine eye drops can prevent nearsightedness (myopia) in children. Atropine is a medicine that has been used to slow myopia, and this trial looks at gradually increasing the dose to find the best approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 6 to 9 years old.
- Your child should have mild farsightedness or a very small amount of nearsightedness — the study has specific levels based on age.
- Your child must not have started any myopia-control treatments yet (like special glasses, contacts, or atropine drops).
- Your child needs to have good vision (20/25 or better) without glasses or contacts.
- Your child must be otherwise healthy, with no major eye problems or serious health issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to prevent or slow down early nearsightedness (myopia) in children ages 3 to 6. It aims to find out if certain eye care methods can help keep their vision healthy.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
This trial tests two low-dose atropine eye drops (0.01% and 0.02%) to see if they can safely slow down the worsening of nearsightedness (myopia) in children. Your child would receive either one of these drops or a placebo (an inactive drop) once daily for up to 2 years.
This study tests if low-dose atropine eye drops can slow down worsening nearsightedness in children. Children in the study receive either the drops or no treatment, and their vision changes are tracked over time.
This trial tests whether atropine eye drops can slow down worsening nearsightedness (myopia) in children and teenagers. It may help keep their eyesight from getting worse over time.
This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.
Hear when a new Pre-myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.